| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 10/26/2023 | 95.85% | Morgan Stanley | $415 → $378 | Maintains | Overweight |
| 10/24/2023 | 102.07% | Stifel | $430 → $390 | Maintains | Buy |
| 09/14/2023 | — | OTR Global | Upgrades | Mixed → Positive | |
| 08/30/2023 | 133.16% | HSBC | → $450 | Initiates Coverage On | → Buy |
| 08/24/2023 | 122.8% | Stifel | $390 → $430 | Maintains | Buy |
| 07/27/2023 | 115.03% | Morgan Stanley | $383 → $415 | Maintains | Overweight |
| 07/27/2023 | 103.63% | Goldman Sachs | $343 → $393 | Maintains | Neutral |
| 04/28/2023 | 77.72% | Goldman Sachs | $307 → $343 | Maintains | Neutral |
| 04/27/2023 | 91.71% | Piper Sandler | $360 → $370 | Maintains | Overweight |
| 04/27/2023 | 16.58% | B of A Securities | $190 → $225 | Maintains | Underperform |
| 04/19/2023 | 98.45% | Morgan Stanley | $314 → $383 | Maintains | Overweight |
| 04/18/2023 | 102.07% | Stifel | $375 → $390 | Maintains | Buy |
| 03/31/2023 | — | OTR Global | Upgrades | Mixed → Positive | |
| 02/03/2023 | 59.07% | Goldman Sachs | → $307 | Upgrades | Sell → Neutral |
| 02/02/2023 | 94.3% | Evercore ISI Group | $230 → $375 | Maintains | Outperform |
| 02/02/2023 | 94.3% | Stifel | $265 → $375 | Maintains | Buy |
| 02/02/2023 | 59.07% | Goldman Sachs | → $307 | Upgrades | Sell → Neutral |
| 02/02/2023 | 73.58% | Baird | $260 → $335 | Maintains | Outperform |
| 02/02/2023 | 86.53% | Piper Sandler | $255 → $360 | Maintains | Overweight |
| 01/11/2023 | 32.12% | Piper Sandler | $230 → $255 | Maintains | Overweight |
| 10/27/2022 | 37.31% | Stifel | $325 → $265 | Maintains | Buy |
| 10/27/2022 | 19.17% | Piper Sandler | $300 → $230 | Maintains | Overweight |
| 10/27/2022 | 34.72% | Baird | $310 → $260 | Maintains | Outperform |
| 10/27/2022 | -14.51% | Goldman Sachs | $250 → $165 | Maintains | Sell |
| 10/27/2022 | 62.69% | Morgan Stanley | $402 → $314 | Maintains | Overweight |
| 10/17/2022 | 3.63% | B of A Securities | $235 → $200 | Maintains | Underperform |
| 10/13/2022 | 55.44% | Piper Sandler | $340 → $300 | Maintains | Overweight |
| 10/12/2022 | 68.39% | Stifel | $375 → $325 | Maintains | Buy |
| 09/09/2022 | 76.17% | Piper Sandler | $370 → $340 | Maintains | Overweight |
| 07/29/2022 | 91.71% | UBS | $380 → $370 | Maintains | Buy |
| 07/28/2022 | 47.67% | Evercore ISI Group | $310 → $285 | Maintains | Outperform |
| 07/28/2022 | 21.76% | B of A Securities | $260 → $235 | Maintains | Underperform |
| 07/28/2022 | 108.29% | Morgan Stanley | $438 → $402 | Maintains | Overweight |
| 07/28/2022 | 29.53% | Goldman Sachs | $380 → $250 | Downgrades | Buy → Sell |
| 07/28/2022 | 112.44% | Baird | $450 → $410 | Maintains | Outperform |
| 07/28/2022 | 94.3% | Stephens & Co. | $500 → $375 | Maintains | Overweight |
| 07/22/2022 | 91.71% | Piper Sandler | $440 → $370 | Maintains | Overweight |
| 07/20/2022 | 126.94% | Morgan Stanley | $479 → $438 | Maintains | Overweight |
| 07/18/2022 | 96.89% | UBS | $410 → $380 | Maintains | Buy |
| 07/14/2022 | 94.3% | Stifel | $425 → $375 | Maintains | Buy |
| 06/15/2022 | 148.19% | Morgan Stanley | $524 → $479 | Maintains | Overweight |
| 05/04/2022 | 116.58% | Credit Suisse | $722 → $418 | Maintains | Outperform |
| 05/03/2022 | 112.44% | UBS | $500 → $410 | Maintains | Buy |
| 04/28/2022 | 120.21% | Stifel | $575 → $425 | Maintains | Buy |
| 04/28/2022 | 171.5% | Morgan Stanley | $575 → $524 | Maintains | Overweight |
| 04/28/2022 | 164.25% | Baird | $625 → $510 | Maintains | Outperform |
| 04/28/2022 | 127.98% | Piper Sandler | $600 → $440 | Maintains | Overweight |
| 04/26/2022 | 159.07% | UBS | $620 → $500 | Maintains | Buy |
| 04/21/2022 | 210.88% | Piper Sandler | $740 → $600 | Maintains | Overweight |
| 04/12/2022 | 203.11% | Evercore ISI Group | $600 → $585 | Maintains | Outperform |
| 02/03/2022 | 159.07% | B of A Securities | $550 → $500 | Maintains | Underperform |
| 02/03/2022 | 274.09% | Credit Suisse | $782 → $722 | Maintains | Outperform |
| 02/03/2022 | 223.83% | Stifel | $675 → $625 | Maintains | Buy |
| 01/31/2022 | 221.24% | UBS | $800 → $620 | Upgrades | Neutral → Buy |
| 01/31/2022 | 197.93% | Morgan Stanley | → $575 | Initiates Coverage On | → Overweight |
| 11/11/2021 | 314.51% | UBS | $750 → $800 | Maintains | Neutral |
| 10/28/2021 | 327.46% | Piper Sandler | $775 → $825 | Maintains | Overweight |
| 10/28/2021 | 288.6% | Evercore ISI Group | $740 → $750 | Maintains | Outperform |
| 09/30/2021 | 279.27% | Credit Suisse | → $732 | Assumes | Outperform → Outperform |
| 07/29/2021 | 298.96% | Wolfe Research | $711 → $770 | Maintains | Outperform |
| 07/29/2021 | 301.55% | Piper Sandler | $735 → $775 | Maintains | Overweight |
| 07/29/2021 | 279.27% | Credit Suisse | $715 → $732 | Maintains | Outperform |
| 07/09/2021 | 262.69% | Stephens & Co. | $600 → $700 | Upgrades | Equal-Weight → Overweight |
| 07/08/2021 | 309.33% | BNP Paribas | → $790 | Initiates Coverage On | → Outperform |
| 05/14/2021 | 210.88% | Stephens & Co. | $710 → $600 | Maintains | Equal-Weight |
| 04/29/2021 | 298.96% | SVB Leerink | $690 → $770 | Maintains | Outperform |
| 04/29/2021 | 288.6% | Stifel | $650 → $750 | Maintains | Buy |
| 04/29/2021 | 280.83% | Piper Sandler | $700 → $735 | Maintains | Overweight |
| 04/29/2021 | 270.47% | Credit Suisse | $693 → $715 | Maintains | Outperform |
| 04/22/2021 | 253.89% | Berenberg | → $683 | Upgrades | Hold → Buy |
| 04/15/2021 | 257.51% | SVB Leerink | $680 → $690 | Maintains | Outperform |
| 02/09/2021 | 257.51% | Wolfe Research | $620 → $690 | Maintains | Outperform |
| 02/04/2021 | 262.69% | Piper Sandler | $610 → $700 | Maintains | Overweight |
| 02/04/2021 | 187.56% | Barclays | $475 → $555 | Maintains | Equal-Weight |
| 02/04/2021 | 252.33% | Evercore ISI Group | $625 → $680 | Maintains | Outperform |
| 02/04/2021 | 226.42% | Credit Suisse | $618 → $630 | Maintains | Outperform |
| 02/04/2021 | 252.33% | SVB Leerink | $620 → $680 | Maintains | Outperform |
| 02/02/2021 | 216.06% | Piper Sandler | $525 → $610 | Maintains | Overweight |
| 02/01/2021 | 223.83% | Goldman Sachs | $561 → $625 | Maintains | Buy |
| 01/27/2021 | 208.29% | UBS | $415 → $595 | Maintains | Neutral |
| 01/04/2021 | 221.24% | Wolfe Research | $500 → $620 | Maintains | Outperform |
| 01/04/2021 | 223.83% | Evercore ISI Group | → $625 | Upgrades | In-Line → Outperform |
| 11/24/2020 | 166.84% | Credit Suisse | $432 → $515 | Maintains | Outperform |
| 11/24/2020 | 169.43% | SVB Leerink | $460 → $520 | Maintains | Outperform |
| 10/28/2020 | 166.84% | Stifel | $460 → $515 | Maintains | Buy |
| 10/23/2020 | 115.03% | UBS | $312 → $415 | Maintains | Neutral |
| 10/23/2020 | 144.56% | Goldman Sachs | $355 → $472 | Maintains | Buy |
| 10/22/2020 | 138.34% | Stifel | $360 → $460 | Maintains | Buy |
| 10/22/2020 | 107.25% | Stephens & Co. | $280 → $400 | Maintains | Equal-Weight |
| 10/22/2020 | 107.25% | Barclays | $300 → $400 | Maintains | Equal-Weight |
| 10/22/2020 | 133.16% | Baird | $370 → $450 | Maintains | Outperform |
| 10/22/2020 | 159.07% | Piper Sandler | $400 → $500 | Maintains | Overweight |
| 10/22/2020 | 123.83% | Credit Suisse | $348 → $432 | Maintains | Outperform |
| 10/22/2020 | 133.16% | Jefferies | $355 → $450 | Maintains | Buy |
| 10/22/2020 | 138.34% | SVB Leerink | $340 → $460 | Maintains | Outperform |
| 07/29/2020 | 58.55% | Berenberg | → $306 | Downgrades | Buy → Hold |
| 07/23/2020 | 73.58% | Goldman Sachs | $294 → $335 | Maintains | Buy |
| 07/23/2020 | 55.44% | Barclays | $225 → $300 | Downgrades | Overweight → Equal-Weight |
| 07/23/2020 | 78.76% | Piper Sandler | $258 → $345 | Maintains | Overweight |
| 07/23/2020 | 76.17% | SVB Leerink | $310 → $340 | Maintains | Outperform |
| 07/20/2020 | 45.08% | B of A Securities | → $280 | Downgrades | Neutral → Underperform |
| 07/17/2020 | 81.35% | Stifel | $300 → $350 | Maintains | Buy |
| 07/14/2020 | 60.62% | SVB Leerink | $260 → $310 | Maintains | Outperform |
| 06/12/2020 | 55.44% | Stifel | $275 → $300 | Maintains | Buy |
| 06/10/2020 | 68.39% | Baird | $248 → $325 | Maintains | Outperform |
| 05/22/2020 | 42.49% | Stifel | $230 → $275 | Maintains | Buy |
| 05/01/2020 | 26.94% | UBS | $270 → $245 | Maintains | Neutral |
| 04/30/2020 | 42.49% | Credit Suisse | $320 → $275 | Maintains | Outperform |
| 03/19/2020 | -14.51% | Stephens & Co. | $220 → $165 | Maintains | Equal-Weight |
| 03/13/2020 | 42.49% | Stifel | $305 → $275 | Maintains | Buy |
| 01/31/2020 | 39.9% | UBS | $280 → $270 | Maintains | Neutral |
| 01/28/2020 | 45.08% | UBS | $235 → $280 | Maintains | Neutral |
| 01/02/2020 | 68.39% | Baird | $276 → $325 | Maintains | Outperform |
| 11/18/2019 | 58.03% | Stifel | $290 → $305 | Maintains | Buy |
| 10/07/2019 | 40.93% | Barclays | $300 → $272 | Maintains | Overweight |
| 07/26/2019 | 34.2% | Baird | $336 → $259 | Maintains | Outperform |
| 07/25/2019 | 13.99% | Evercore ISI Group | $340 → $220 | Downgrades | Outperform → In-Line |
| 04/25/2019 | 83.94% | Barclays | $335 → $355 | Maintains | Overweight |
| 04/18/2019 | 73.58% | Guggenheim | → $335 | Initiates Coverage On | → Buy |
| 03/05/2019 | 48.19% | Baird | $255 → $286 | Maintains | Outperform |
| 02/14/2019 | — | UBS | Downgrades | Buy → Neutral | |
| 01/17/2019 | 19.17% | UBS | → $230 | Initiates Coverage On | → Buy |
| 01/04/2019 | 8.81% | Morgan Stanley | $300 → $210 | Maintains | Equal-Weight |
| 11/20/2018 | 77.72% | Credit Suisse | $375 → $343 | Maintains | Outperform |
What is the target price for Align Tech (ALGN)?
The latest price target for Align Tech (NASDAQ: ALGN) was reported by Morgan Stanley on October 26, 2023. The analyst firm set a price target for $378.00 expecting ALGN to rise to within 12 months (a possible 95.85% upside). 25 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Align Tech (ALGN)?
The latest analyst rating for Align Tech (NASDAQ: ALGN) was provided by Morgan Stanley, and Align Tech maintained their overweight rating.
When is the next analyst rating going to be posted or updated for Align Tech (ALGN)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Align Tech, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Align Tech was filed on October 26, 2023 so you should expect the next rating to be made available sometime around October 26, 2024.
Is the Analyst Rating Align Tech (ALGN) correct?
While ratings are subjective and will change, the latest Align Tech (ALGN) rating was a maintained with a price target of $415.00 to $378.00. The current price Align Tech (ALGN) is trading at is $193.00, which is out of the analyst's predicted range.